The inhibitory role of Mir-29 in growth of breast cancer cells

Journal of Experimental and Clinical Cancer Research

Volumn 32, Issue 1, 2013, Pages

  Wu, Zhenglong ^a   Huang, Xiaona ^b   Huang, Xing ^a   Zou, Qiang ^c   Guo, Yujiang ^a  

^a WUXI PEOPLE S HOSPITAL AFFILIATED TO NANJING MEDICAL UNIVERSITY   (China)

^b Wuxi Traditional Chinese Medicine Hospital   (China)

^c FUDAN UNIVERSITY   (China)

Author keywords

Apoptosis; Breast cancer growth; Cancer progression; Mir 29

Indexed keywords

CYCLIN A2; CYCLIN D1; MICRORNA 29A; RNA ISOFORM; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR B MYB; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST CELL; CANCER GROWTH; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE SILENCING; GROWTH INHIBITION; GROWTH RATE; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

BASE SEQUENCE; BREAST NEOPLASMS; CELL CYCLE PROTEINS; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; DOWN-REGULATION; FEMALE; GENE KNOCKDOWN TECHNIQUES; GENETIC THERAPY; HUMANS; MCF-7 CELLS; MICRORNAS; TRANS-ACTIVATORS; TRANSFECTION; TUMOR MARKERS, BIOLOGICAL;

EID: 84888378462     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-32-98     Document Type: Article

References (31)

1. Cancer statistics, 2009. Jemal A, et al. CA Cancer J Clin 2009 59 4 225 249 10.3322/caac.20006 19474385
2. Striking life events associated with primary breast cancer susceptibility in women: a meta-analysis study. Lin Y, et al. J Exp Clin Cancer Res 2013 32 1 53 10.1186/1756-9966-32-53 23941600
3. MicroRNA gene expression deregulation in human breast cancer. Iorio MV, et al. Cancer Res 2005 65 16 7065 7070 10.1158/0008-5472.CAN-05-1783 16103053 (Pubitemid 41161233)
4. MicroRNA-203 suppresses cell proliferation and migration by targeting BIRC5 and LASP1 in human triple-negative breast cancer cells. Wang C, et al. J Exp Clin Cancer Res 2012 31 58 10.1186/1756-9966-31-58 22713668
5. MicroRNAs: target recognition and regulatory functions. Bartel DP, Cell 2009 136 2 215 233 10.1016/j.cell.2009.01.002 19167326
6. Effect of microRNA-34a in cell cycle, differentiation, and apoptosis: a review. Chen F, Hu SJ, J Biochem Mol Toxicol 2012 26 2 79 86 10.1002/jbt.20412 22162084
7. MicroRNAs: small RNAs with a big role in gene regulation. He L, Hannon GJ, Nat Rev Genet 2004 5 7 522 531 10.1038/nrg1379 15211354 (Pubitemid 38868508)
8. A miRNA-regulatory network explains how dysregulated miRNAs perturb oncogenic processes across diverse cancers. Plaisier CL, Pan M, Baliga NS, Genome Res 2012 22 11 2302 2314 10.1101/gr.133991.111 22745231
9. Decrease expression of microRNA-20a promotes cancer cell proliferation and predicts poor survival of hepatocellular carcinoma. Fan MQ, et al. J Exp Clin Cancer Res 2013 32 1 21 10.1186/1756-9966-32-21 23594563
10. MicroRNA signatures in human cancers. Calin GA, Croce CM, Nat Rev Cancer 2006 6 11 857 866 10.1038/nrc1997 17060945 (Pubitemid 44629897)
11. Integrated analyses of microRNAs demonstrate their widespread influence on gene expression in high-grade serous ovarian carcinoma. Creighton CJ, et al. PLoS One 2012 7 3 34546 10.1371/journal.pone.0034546 22479643
12. MicroRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphoma. Zhao JJ, et al. Blood 2010 115 13 2630 2639 10.1182/blood-2009-09-243147 20086245
13. MicroRNA 29b functions in acute myeloid leukemia. Garzon R, et al. Blood 2009 114 26 5331 5341 10.1182/blood-2009-03-211938 19850741
14. APOBEC3G promotes liver metastasis in an orthotopic mouse model of colorectal cancer and predicts human hepatic metastasis. Ding Q, et al. J Clin Invest 2011 121 11 4526 4536 10.1172/JCI45008 21985787
15. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Fabbri M, et al. Proc Natl Acad Sci USA 2007 104 40 15805 15810 10.1073/pnas.0707628104 17890317 (Pubitemid 350035380)
16. Progestin suppression of miR-29 potentiates dedifferentiation of breast cancer cells via KLF4. Cittelly DM, et al. Oncogene 2012 2 20 2555 2564
17. miR-29a suppresses tristetraprolin, which is a regulator of epithelial polarity and metastasis. Gebeshuber CA, Zatloukal K, Martinez J, Embo Reports 2009 10 4 400 405 10.1038/embor.2009.9 19247375
18. Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma. Xiong Y, et al. Hepatology 2010 51 3 836 845 20041405
19. A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. Calin GA, et al. N Engl J Med 2005 353 17 1793 1801 10.1056/NEJMoa050995 16251535 (Pubitemid 41549891)
20. mir-29 regulates Mcl-1 protein expression and apoptosis. Mott JL, et al. Oncogene 2007 26 42 6133 6140 10.1038/sj.onc.1210436 17404574 (Pubitemid 47414372)
21. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Yanaihara N, et al. Cancer Cell 2006 9 3 189 198 10.1016/j.ccr.2006. 01.025 16530703 (Pubitemid 43357945)
22. miR-29 and miR-30 regulate B-Myb expression during cellular senescence. Martinez I, et al. Proc Natl Acad Sci U S A 2011 108 2 522 527 10.1073/pnas.1017346108 21187425
23. MiRNA-29a regulates the expression of numerous proteins and reduces the invasiveness and proliferation of human carcinoma cell lines. Muniyappa MK, et al. Eur J Cancer 2009 45 17 3104 3118 10.1016/j.ejca.2009.09.014 19818597
24. MicroRNA miR-29 modulates expression of immunoinhibitory molecule B7-H3: potential implications for immune based therapy of human solid tumors. Xu H, et al. Cancer Res 2009 69 15 6275 6281 10.1158/0008-5472.CAN-08-4517 19584290
25. Chronic lymphocytic leukemia modeled in mouse by targeted miR-29 expression. Santanam U, et al. Proc Natl Acad Sci U S A 2010 107 27 12210 12215 10.1073/pnas.1007186107 20566844
26. MiR-29a inhibits cell proliferation and induces cell cycle arrest through the downregulation of p42.3 In human gastric cancer. Cui Y, et al. Plos One 2011 6 10 25872 10.1371/journal.pone.0025872 21998710
27. B-MYB, a transcription factor implicated in regulating cell cycle, apoptosis and cancer. Sala A, Eur J Cancer 2005 41 16 2479 2484 10.1016/j.ejca.2005.08.004 16198555 (Pubitemid 41540624)
28. Cyclin D1 and breast cancer. Roy PG, Thompson AM, Breast 2006 15 6 718 727 10.1016/j.breast.2006.02.005 16675218 (Pubitemid 44774238)
29. Expression of cyclin A in soft tissue sarcomas correlates with tumor aggressiveness. Huuhtanen RL, et al. Cancer Res 1999 59 12 2885 2890 10383150 (Pubitemid 29283127)
30. Cyclin A as a marker for prognosis and chemotherapy response in advanced breast cancer. Poikonen P, et al. Br J Cancer 2005 93 5 515 519 10.1038/sj.bjc.6602735 16091759 (Pubitemid 43079993)
31. Knocking-down cyclin A(2) by siRNA suppresses apoptosis and switches differentiation pathways in K562 cells upon administration with doxorubicin. Wang X, et al. PLoS One 2009 4 8 6665 10.1371/journal.pone.0006665 19684852